| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $100.4M | — | +16.9% |
| Cost of Revenue | $41.8M | — | +21.6% |
| Gross Profit | $58.6M | — | +13.7% |
| R&D Expense | $58.1M | — | -1.2% |
| SG&A Expense | $19.9M | — | +6.9% |
| Operating Income | -$19.4M | — | +24.9% |
| Pre-tax Income | -$17.3M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $114.4M | -40.1% | -19.0% |
| Accounts Receivable | $39.2M | -0.0% | +29.6% |
| Inventory | $80.4M | +53.8% | +104.5% |
| Current Assets | $405.2M | -1.2% | +20.8% |
| Total Assets | $794.8M | -0.5% | +13.2% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.6M | — | -273.1% |
| Investing Cash Flow | -$46.3M | — | -186.6% |
| Financing Cash Flow | -$4.7M | — | -200.4% |
| +26.8% |
| Income Tax | $760K | — | +17.8% |
| Net Income | -$18.1M | — | +25.6% |
| EPS (Basic) | -$0.41 | — | +29.3% |
| EPS (Diluted) | -$0.41 | — | +29.3% |
| $167.0M |
| -6.2% |
| +33.7% |
| Total Liabilities | $189.0M | -7.3% | +46.3% |
| Stockholders' Equity | $605.8M | +1.9% | +5.8% |